1 |
The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
53
62
|
Lu S...Carlson JA
|
20482673 |
2010 |
2 |
Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
53
62
|
Takata M...Saida T
|
19788535 |
2010 |
3 |
Malignant melanoma--a genetic overview.
53
62
|
Bloethner S...Kumar R
|
20096196 |
2009 |
4 |
Polyclonality of BRAF mutations in acquired melanocytic nevi.
53
62
|
Lin J...Saida T
|
19752400 |
2009 |
5 |
Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.
53
62
|
Uribe P...Gonzalez S
|
19461239 |
2009 |
6 |
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
53
62
|
Yu H...Xu X
|
19389934 |
2009 |
7 |
Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
53
62
|
Houben R...Becker JC
|
18650848 |
2009 |
8 |
Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
53
62
|
Fullen DR...Thomas D
|
18201235 |
2008 |
9 |
G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
53
62
|
Stefanaki C...Katsambas A
|
18494826 |
2008 |
10 |
Differential gene expression in melanocytic nevi with the V600E BRAF mutation.
53
62
|
Bloethner S...Kumar R
|
17696195 |
2007 |
11 |
Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
53
62
|
Dessars B...Heimann P
|
17301836 |
2007 |
12 |
The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
53
62
|
Lebe B...Ozer E
|
17525627 |
2007 |
13 |
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
53
62
|
Bauer J...Bastian BC
|
16888631 |
2007 |
14 |
BRAF and NRAS mutations in spitzoid melanocytic lesions.
53
62
|
Fullen DR...Gruber SB
|
16799476 |
2006 |
15 |
BRAF and NRAS mutations in melanoma and melanocytic nevi.
53
62
|
Poynter JN...Gruber SB
|
16845322 |
2006 |
16 |
Genetic alterations in melanocytic tumors.
53
62
|
Takata M...Saida T
|
16750612 |
2006 |
17 |
Implication of MT1-MMP in the maturation steps of benign melanocytic nevi.
53
62
|
Perez LJ...Garcia-Diez A
|
16420309 |
2006 |
18 |
Absence of mutations in the coding sequence of the potential tumor suppressor 3pK in metastatic melanoma.
53
62
|
Houben R...Rapp UR
|
16367997 |
2005 |
19 |
Fatty acid synthase expression in cutaneous melanocytic neoplasms.
53
62
|
Kapur P...Hoang MP
|
15920554 |
2005 |
20 |
Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
53
62
|
Kapur P...Hoang MP
|
15467715 |
2005 |
21 |
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
53
62
|
Tsavachidou D...Weber BL
|
15313890 |
2004 |
22 |
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
53
62
|
Tsao H...Haluska FG
|
15009714 |
2004 |
23 |
BRAF mutations are common somatic events in melanocytic nevi.
53
62
|
Kumar R...Hemminki K
|
15009715 |
2004 |
24 |
BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
53
62
|
Uribe P...Gonzalez S
|
14501284 |
2003 |
25 |
Expression of translation initiation factor eIF-2alpha is increased in benign and malignant melanocytic and colonic epithelial neoplasms.
53
62
|
Rosenwald IB...Pullman J
|
12942578 |
2003 |
26 |
BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
53
62
|
Dong J...Aaronson SA
|
12873977 |
2003 |
27 |
S100A6 protein expression is different in Spitz nevi and melanomas.
53
62
|
Ribe A...McNutt NS
|
12748257 |
2003 |
28 |
MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light.
53
62
|
Krengel S...Tronnier M
|
12139633 |
2002 |
29 |
Loss of p14ARF expression in melanoma.
53
62
|
Dobrowolski R...Bosserhoff AK
|
11876522 |
2002 |
30 |
S100A6 expression in fibrohistiocytic lesions.
53
62
|
Fullen DR...McNutt NS
|
11401666 |
2001 |
31 |
Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
53
62
|
Busam KJ...Jungbluth AA
|
10871066 |
2000 |
32 |
A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
53
62
|
Bergman R...Ben-Itzhak O
|
10688724 |
2000 |
33 |
A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
53
62
|
Zhu G...Martin NG
|
10417291 |
1999 |
34 |
Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression.
53
62
|
Zhang XD...Hersey P
|
10503270 |
1999 |
35 |
Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines.
53
62
|
Schittek B...Garbe C
|
10404074 |
1999 |
36 |
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
53
62
|
Busam KJ...Jungbluth AA
|
9706977 |
1998 |
37 |
Prognostic significance of allelic losses in primary melanoma.
53
62
|
Healy E...Rees JL
|
9619830 |
1998 |
38 |
Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.
53
62
|
Talve L...Ekfors T
|
9221801 |
1997 |
39 |
Expression of nerve growth factor and epidermal growth factor receptors in neural nevi with nevic corpuscles.
53
62
|
Argenyi ZB...Wick M
|
8902091 |
1996 |
40 |
Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.
53
62
|
Saenz-Santamaria MC...Shea CR
|
7868749 |
1994 |
41 |
Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
53
62
|
Brocker EB...Herlyn M
|
1850772 |
1991 |
42 |
Cutaneous glomus tumor. A comparative immunohistochemical study with pseudoangiomatous intradermal melanocytic nevi.
53
62
|
Kaye VM...Dehner LP
|
1848411 |
1991 |
43 |
Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms.
53
62
|
Gray MH...Hsu A
|
1693815 |
1990 |
44 |
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
53
62
|
Gray MH...Hsu A
|
1690969 |
1990 |
45 |
Transcriptomic analysis of mRNA expression in giant congenital melanocytic nevi.
62
|
Cheng X...Dai T
|
36174903 |
2023 |
46 |
FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
62
|
Zengin HB...Smoller BR
|
36454046 |
2022 |
47 |
The long-term evolution of melanocytic nevi among high-risk adults.
62
|
Reiter O...Rotemberg V
|
35881111 |
2022 |
48 |
SCALP syndrome with a germline heterozygous DOCK6 mutation and somatic mosaic NRAS Q61R mutation.
62
|
Meyer SN...Kiuru M
|
36456540 |
2022 |
49 |
Analyzing the Spatial Randomness in the Distribution of Acquired Melanocytic Neoplasms.
62
|
Chousakos E...Marghoob AA
|
35841946 |
2022 |
50 |
Congenital Melanocytic Nevi Syndrome With Leptomeningeal Melanoma.
62
|
Mohite A...Rangarajan V
|
35867990 |
2022 |